Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries CinCor Pharma, Inc. - Common Stock (NQ: CINC ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Feb 23, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about CinCor Pharma, Inc. - Common Stock CinCor Pharma Announces Receipt of Minutes from End-of-Phase 2 Meeting with the U.S. Food and Drug Administration on Planned Phase 3 Program of Baxdrostat February 21, 2023 From CinCor Pharma Inc Via GlobeNewswire There's a Lot to Love About Mineralys' Valentine's Day IPO February 13, 2023 MLYS added 20% more shares to IPO funding, which goes live on 2/14. The bump secured liquidity to stabilize development, improving market cap to $683 million Via MarketBeat Topics Initial Public Offering Exposures Securities Market These 2 Healthcare Stocks Have Doubled in 2023 February 01, 2023 Wouldn’t it be great if a stock had a bulkier capitalization and 2x potential? This is rare but possible for these two small-mid health care stocks. Via MarketBeat CINCOR PHARMA INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CinCor Pharma, Inc. - CINC January 24, 2023 From Kahn Swick & Foti, LLC Via Business Wire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Paya Holdings Inc. (Nasdaq – PAYA), CinCor Pharma, Inc. (Nasdaq – CINC), Albireo (Nasdaq – ALBO), Duck Creek Technologies (Nasdaq - DCT) January 20, 2023 From Brodsky & Smith LLC Via GlobeNewswire CINCOR PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CinCor Pharma, Inc. - CINC January 10, 2023 From Kahn Swick & Foti, LLC Via Business Wire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Paya Holdings Inc. (Nasdaq – PAYA), CinCor Pharma, Inc. (Nasdaq – CINC), Albireo (Nasdaq – ALBO), Duck Creek Technologies (Nasdaq - DCT) January 10, 2023 From Brodsky & Smith LLC Via GlobeNewswire CinCor Pharma (NASDAQ: CINC) Enters Into Agreement to be Acquired by AstraZeneca (NASDAQ: AZN) for $1.3 Billion January 09, 2023 CinCor Pharma, Inc. (NASDAQ: CINC) is a clinical-stage biopharmaceutical company, which is focused on the research and development of treatments Via Spotlight Growth CINC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of CinCor Pharma, Inc. Is Fair to Shareholders January 09, 2023 From Halper Sadeh LLC Via Business Wire CinCor Pharma to be Acquired by AstraZeneca January 09, 2023 From CinCor Pharma Inc Via GlobeNewswire Correcting and Replacing: CinCor Reports Third Quarter Financial Results and Provides Corporate Update November 04, 2022 From CinCor Pharma Inc Via GlobeNewswire CinCor Reports Third Quarter Financial Results and Provides Corporate Update November 03, 2022 From CinCor Pharma Inc Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.